Atlas Trials

EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion

Clinical trial NCT00647192 · TERMINATED

Trial details

NCT number
NCT00647192
Sponsor
University Hospital, Saarland
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Atrial Fibrillation
Start date
2008-03-01
Primary completion
2012-02-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.